BioAge Labs (BIOA) Metrics: History & Chart

BioAge Labs Inc.(BIOA)

Biotechnology · Emeryville, CA

$6.08-0.29 (-4.48%)

Delayed quote: Oct 6, 2026, 1:20 PM EDT

About BioAge Labs Inc.

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.

Emeryville, CA

61 employees

bioagelabs.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Kristen Fortney

View full financials

Third-Party DCF Estimate (FMP)	$8.72
Price Gap vs Third-Party Estimate	+37.18%

7D Total Return	-11.42%
30D Total Return	-33.68%
YTD Total Return	-51.93%
1Y Total Return	+13.37%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-51.93%
2025	+128.50%
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	+13.30%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

BIOA Valuation Metrics

BIOA Stock Price Metrics

BIOA Dividend Metrics

BIOA Growth Rate Metrics

BIOA Discounted Cash Flow Metrics

BIOA Returns By Period

BIOA Yearly Returns

BIOA Average Annual Returns By Period (CAGR)

BIOA Revenue Metrics

BIOA PE Ratio Metrics

BIOA PS Ratio Metrics

BIOA PB Ratio Metrics

BIOA Price to Free Cash Flow Ratio Metrics

BIOA Debt to Equity Ratio Metrics

BIOA PEG Ratio Metrics

BIOA FCF Yield

BIOA Earnings Yield

BIOA EBITDA Yield

BIOA OCF Yield

BIOA EV/EBIT Ratio Metrics

BIOA EV/EBITDA Ratio Metrics

BIOA EV/Assets Ratio Metrics

BIOA EV/Sales Ratio Metrics

BIOA Current Ratio Metrics

BIOA Quick Ratio Metrics

BIOA ROIC Metrics

BIOA Return on Assets Metrics

BIOA Return on Equity Metrics

BIOA Net Profit Margin Metrics

BIOA Gross Profit Margin Metrics

BIOA Tax Rate Metrics

PS Ratio	27.54
PS Ratio Avg TTM	76.33
PS Ratio Avg 3Y	78.08
Current VS TTM Avg	-63.92%
Current VS 3Y Avg	-64.73%
Current VS 5Y Avg	-64.73%

PB Ratio	0.76
PB Ratio Avg TTM	1.84
PB Ratio Avg 3Y	1.28
Current VS TTM Avg	-58.68%
Current VS 3Y Avg	-40.57%
Current VS 5Y Avg	-40.57%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.02
Debt/Equity Ratio Avg 3Y	0.02
Current VS TTM Avg	-59.79%
Current VS 3Y Avg	-59.44%
Current VS 5Y Avg	-55.38%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.54
Ev/Assets Ratio Avg TTM	1.20
Ev/Assets Ratio Avg 3Y	1.18
Current VS TTM Avg	-54.93%
Current VS 3Y Avg	-54.13%
Current VS 5Y Avg	-54.13%

Ev/Sales Ratio	20.67
Ev/Sales Ratio Avg TTM	51.44
Ev/Sales Ratio Avg 3Y	51.23
Current VS TTM Avg	-59.82%
Current VS 3Y Avg	-59.65%
Current VS 5Y Avg	-59.65%

Current Ratio	17.19
Current Ratio Avg TTM	16.25
Current Ratio Avg 3Y	13.90
Current VS TTM Avg	+5.74%
Current VS 3Y Avg	+23.65%
Current VS 5Y Avg	+60.11%

Quick Ratio	17.19
Quick Ratio Avg TTM	16.25
Quick Ratio Avg 3Y	13.90
Current VS TTM Avg	+5.74%
Current VS 3Y Avg	+23.65%
Current VS 5Y Avg	+60.11%

ROIC	(28.14%)
ROIC Avg 3Y	(60.37%)
ROIC Avg 5Y	(60.37%)
Current VS 3Y Avg	+53.39%
Current VS 5Y Avg	+53.39%
Current VS 10Y Avg	+53.39%

ROA	(23.80%)
ROA Avg TTM	(6.85%)
ROA Avg 3Y	(6.64%)
Current VS TTM Avg	-247.21%
Current VS 3Y Avg	-258.63%
Current VS 5Y Avg	-366.22%

ROE	(25.20%)
ROE Avg TTM	(26.53%)
ROE Avg 3Y	(25.00%)
Current VS TTM Avg	+5.03%
Current VS 3Y Avg	-0.81%
Current VS 5Y Avg	-0.81%

Net Profit Margin	(912.25%)
Net Profit Margin Avg TTM	(917.28%)
Net Profit Margin Avg 3Y	(421.34%)
Current VS TTM Avg	+0.55%
Current VS 3Y Avg	-116.51%
Current VS 5Y Avg	-133.17%

Gross Profit Margin	99.39%
Gross Pft Margin Avg TTM	99.55%
Gross Pft Margin Avg 3Y	45.98%
Current VS TTM Avg	-0.16%
Current VS 3Y Avg	+116.16%
Current VS 5Y Avg	+132.79%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A